Abstract
Cutaneous zygomycosis is a rare but severe fungal infection with high risk of dissemination. Early recognition, deep surgical biopsy for diagnosis, aggressive treatment with repeated surgical debridement, and targeted pharmacotherapy are essential and can prevent dissemination and fatal outcome. We present case reports of 2 patients.
MeSH terms
-
Amphotericin B / administration & dosage
-
Amphotericin B / therapeutic use
-
Antifungal Agents / administration & dosage
-
Antifungal Agents / therapeutic use
-
Child
-
Child, Preschool
-
Debridement
-
Dermatomycoses / diagnosis*
-
Dermatomycoses / drug therapy
-
Dermatomycoses / surgery
-
Dermatomycoses / therapy*
-
Female
-
Humans
-
Hyperbaric Oxygenation
-
Immunocompromised Host
-
Male
-
Neutropenia / complications
-
Treatment Outcome
-
Zygomycosis / diagnosis*
-
Zygomycosis / drug therapy
-
Zygomycosis / surgery
-
Zygomycosis / therapy*
Substances
-
Antifungal Agents
-
liposomal amphotericin B
-
Amphotericin B